Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Single Arm, Phase I Clinical Study of HS-IT101 Injection in the Treatment of Advanced Solid Tumors

NCT06342336 is registered in ClinicalTrials.gov with Qingdao Sino-Cell Biomedicine Co., Ltd. as lead sponsor.

NCT NCT06342336
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06342336 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Single Arm, Phase I Clinical Study of HS-IT101 Injection in the Treatment of Advanced Solid Tumors
Lead sponsor
Qingdao Sino-Cell Biomedicine Co., Ltd.
Phase
Phase 1
Overall status
Recruiting
Start date
January 18, 2024
Completion date
March 31, 2028
Enrollment
44 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

solid tumor